K.a.b.s. Laboratories Inc. - Kabs

Where the EU money came from

Funding by EU programme. Amounts are K.a.b.s. Laboratories Inc. - Kabs's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• ImpentriPartner

  Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS).

  Horizon 2020 · 2020–2022 · Project on CORDIS ↗

  €438ktheir share
• ELIMOXPartner

  Biopharmaceutical therapy for treatment of Primary Hyperoxaluria

  FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek TNONetherlands · 1 shared project
• Stichting Amsterdam UmcNetherlands · 1 shared project
• Academisch Medisch Centrum Bij de Universiteit van AmsterdamNetherlands · 1 shared project
• Universitatsklinikum BonnGermany · 1 shared project
• Hospices Civils de LyonFrance · 1 shared project
• University College London Hospitalsnhs Foundation TrustUnited Kingdom · 1 shared project
• Exvastat LtdUnited Kingdom · 1 shared project
• Oxthera ABSweden · 1 shared project
• Orion Sante SARLFrance · 1 shared project
• Cobra Biologics LimitedUnited Kingdom · 1 shared project
• Symbio Pharm GmbHGermany · 1 shared project
• Bio-Images Research LimitedUnited Kingdom · 1 shared project
• Ergomed Clinical Research LimitedUnited Kingdom · 1 shared project
• Galenica ABSweden · 1 shared project
• Medizinisches Versorgungszentrum Institut Fur Mikrookologie GmbHGermany · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• bacteriology
• coronaviruses
• immunology
• manufacturing engineering
• mortality
• pathology
• pharmaceutical drugs
• pharmacokinetics